Circulating extracellular vesicles exhibit a differential miRNA profile in gestational diabetes mellitus pregnancies.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2022
2022
Historique:
received:
24
11
2021
accepted:
11
04
2022
entrez:
25
5
2022
pubmed:
26
5
2022
medline:
28
5
2022
Statut:
epublish
Résumé
We undertook a prospective temporal study collecting blood samples from consenting pregnant women, to test the hypothesis that circulating extracellular vesicles (EVs) carrying specific non-coding microRNA signatures can underlie gestational diabetes mellitus (GDM). To test this hypothesis, miRNA cargo of isolated and characterized EVs revealed contributions from the placenta and differential expression at all three trimesters and at delivery between pregnant and non-pregnant states. Many miRNAs originate from the placental-specific chromosome 19 microRNA cluster (19MC) and chromosome 14 microRNA cluster (14MC). Further a positive correlation emerged between third trimester and at delivery EVs containing miRNAs and those expressed by the corresponding post-parturient placentas (R value = 0.63 to 0.69, p value = 2.2X10-16), in normal and GDM. In addition, distinct differences at all trimesters emerged between women who subsequently developed GDM. Analysis by logistic regression with leave-one-out-cross validation revealed the optimal combination of miRNAs using all the circulating miRNAs (miR-92a-3p, miR-192-5p, miR-451a, miR-122-5p), or using only the differentially expressed miRNAs (has-miR-92a-3p, hsa-miR-92b-3p, hsa-miR-100-5p and hsa-miR-125a-3p) in GDM during the first trimester. As an initial step, both sets of miRNAs demonstrated a predictive probability with an area under the curve of 0.95 to 0.96. These miRNAs targeted genes involved in cell metabolism, proliferation and immune tolerance. In particular genes of the P-I-3-Kinase, FOXO, insulin signaling and glucogenic pathways were targeted, suggestive of placental connectivity with various maternal organs/cells, altering physiology along with pathogenic mechanisms underlying the subsequent development of GDM. We conclude that circulating EVs originating from the placenta with their miRNA cargo communicate and regulate signaling pathways in maternal organs, thereby predetermining development of GDM.
Identifiants
pubmed: 35613088
doi: 10.1371/journal.pone.0267564
pii: PONE-D-21-37345
pmc: PMC9132306
doi:
Substances chimiques
MicroRNAs
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0267564Subventions
Organisme : NICHD NIH HHS
ID : R01 HD089714
Pays : United States
Organisme : NICHD NIH HHS
ID : R01 HD100015
Pays : United States
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Placenta. 2013 Nov;34(11):1072-8
pubmed: 24011442
Evid Based Complement Alternat Med. 2020 Mar 06;2020:6050874
pubmed: 32215042
PLoS One. 2013;8(3):e58502
pubmed: 23516492
Epigenetics. 2021 Jun;16(6):642-661
pubmed: 33045922
Int J Mol Sci. 2020 May 14;21(10):
pubmed: 32422900
Endocr Connect. 2017 Nov;6(8):773-790
pubmed: 28986402
Front Endocrinol (Lausanne). 2018 Nov 27;9:696
pubmed: 30538674
RNA Biol. 2013 Aug;10(8):1365-78
pubmed: 24084692
PLoS One. 2014 Jun 06;9(6):e98667
pubmed: 24905832
Mol Hum Reprod. 2012 Aug;18(8):417-24
pubmed: 22383544
Diabetes. 2016 Mar;65(3):598-609
pubmed: 26718504
Int J Mol Sci. 2020 Mar 31;21(7):
pubmed: 32244558
Nucleic Acids Res. 2014 Jan;42(Database issue):D68-73
pubmed: 24275495
Genome Biol. 2009;10(3):R25
pubmed: 19261174
Genome Biol. 2014;15(12):550
pubmed: 25516281
Diabetes Res Clin Pract. 2018 Nov;145:20-30
pubmed: 29852233
Nucleic Acids Res. 2012 Jan;40(1):37-52
pubmed: 21911355
BMC Bioinformatics. 2019 Nov 4;20(1):545
pubmed: 31684860
Eur J Endocrinol. 2019 Nov;181(5):565-577
pubmed: 31539877
Placenta. 2012 Mar;33(3):188-94
pubmed: 22212249
Placenta. 2017 Feb;50:60-69
pubmed: 28161063
Clin Sci (Lond). 2018 Nov 29;132(22):2451-2467
pubmed: 30254065
Mol Med Rep. 2020 Sep;22(3):1868-1882
pubmed: 32705173
Biol Reprod. 2009 Oct;81(4):717-29
pubmed: 19494253
Subcell Biochem. 2021;97:455-482
pubmed: 33779928
FASEB J. 2020 Apr;34(4):5724-5739
pubmed: 32154621
Hypertension. 2020 Mar;75(3):762-771
pubmed: 31983308
Diabetes Care. 2008 Nov;31(11):2126-30
pubmed: 18694977
Proteomics Clin Appl. 2017 Jul;11(7-8):
pubmed: 28220636
BMJ. 2019 Dec 4;367:l6398
pubmed: 31801789
Endocrinology. 2014 Dec;155(12):4975-85
pubmed: 25211593
J Clin Endocrinol Metab. 2019 Nov 1;104(11):5157-5169
pubmed: 31058973
Proteomics. 2019 Jan;19(1-2):e1800164
pubmed: 30536821
Epigenomics. 2021 Jul;13(13):995-1012
pubmed: 34030457
In Vivo. 2020 Mar-Apr;34(2):849-856
pubmed: 32111794
Biomed Res Int. 2014;2014:925350
pubmed: 24864265
Placenta. 2021 Sep 15;113:15-22
pubmed: 33714611
Placenta. 2012 Sep;33(9):725-34
pubmed: 22721760
J Clin Endocrinol Metab. 2015 Oct;100(10):E1280-8
pubmed: 26241326
BMC Med Genomics. 2009 Aug 18;2:54
pubmed: 19689793
Rev Recent Clin Trials. 2018 Jan 31;13(1):5-14
pubmed: 28901851
J Transl Med. 2021 Aug 20;19(1):360
pubmed: 34416903
J Extracell Vesicles. 2018 Nov 23;7(1):1535750
pubmed: 30637094
Int J Gynaecol Obstet. 2015 Jul;130(1):49-53
pubmed: 25887942
Methods Mol Biol. 2018;1710:131-138
pubmed: 29196999
J Transl Med. 2014 Aug 08;12:204
pubmed: 25104112
Int J Mol Sci. 2021 Apr 09;22(8):
pubmed: 33918880
Biochem Biophys Res Commun. 2018 Jun 7;500(3):577-582
pubmed: 29660330
J Extracell Vesicles. 2013 May 27;2:
pubmed: 24009894
PLoS One. 2013 Nov 11;8(11):e79636
pubmed: 24244532
Biomed Rep. 2021 Feb;14(2):24
pubmed: 33408858